For those considering participation in a clinical trial, the following frequently asked questions are important in understanding the role of the participant and the unique process of clinical trials.

This Black History Month, we’re centering the voices, stories, and experiences of Black lupus warriors. Throughout February, we’re sharing resources and community spaces designed to support and ...

The U.S. Food and Drug Administration (FDA) issued a complete response letter requesting additional information from ...

Congress has taken the final steps in the FY 2026 budget process, passing legislation that increases funding for lupus programs, including $27 million - the most in history - for lupus programs at the ...

A new study exploring the investigational therapy, Zorpo-cel, met its primary safety and secondary efficacy endpoints in ...

Learn more about how your company or organization can raise its profile and morale by becoming a corporate partner.

Black History Month serves as a reminder to actively amplify Black voices, share stories and raise awareness throughout the ...

In this episode of the Lupus Foundation of America's The Expert Series podcast, we focus on the newly released American College of Rheumatology treatment guidelines for systemic lupus erythematosus ...

Our approach is innovative and removes barriers to progress. Watch this short video about three of our bold research initiatives to better understand lupus in children and teens, improve early ...

The U.S. Food and Drug Administration (FDA) approved Gazyva® to treat adults with lupus nephritis in October 2025. Gazyva targets and removes harmful B cells to help protect the kidneys in people with ...

You can donate your car, truck, boat or RV to the Lupus Foundation of America and receive a tax deduction while supporting life-changing research. To learn more, fill out this form and a ...